The results showed that the expression levels of PD‐L1 and HLA‐G in advanced NSCLC tumors were higher than those in early‐stage tumors, with no detectable expression observed in the paired normal tissue adjacent to the tumor (NAT) (Figure 1A–E). The gene discussed is BRD2; the disease is neoplasm.